Pharmacological profile of PHA121 published in International Pharmacology Mar 22, 2022 Publication Bradykinin Challenge Provides Surrogate Endpoints For Hereditary Angioedema Treatment Nov 13, 2020 Poster 664.1 KB Presentation PHA-022121, a Selective Bradykinin-B2-Receptor Antagonist, Is Safe and Shows Rapid Oral Bioavailability in Humans Nov 13, 2020 Poster 746.5 KB Presentation In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist Jul 30, 2020 Publication 1.7 MB PHA-022121, a First in Class Oral Bradykinin B2 Receptor Antagonist in Clinical Development: Proof of Concept Study in a Translational Monkey Bradykinin Challenge Model Apr 09, 2020 Poster 931.5 KB
Bradykinin Challenge Provides Surrogate Endpoints For Hereditary Angioedema Treatment Nov 13, 2020 Poster 664.1 KB Presentation
PHA-022121, a Selective Bradykinin-B2-Receptor Antagonist, Is Safe and Shows Rapid Oral Bioavailability in Humans Nov 13, 2020 Poster 746.5 KB Presentation
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist Jul 30, 2020 Publication 1.7 MB
PHA-022121, a First in Class Oral Bradykinin B2 Receptor Antagonist in Clinical Development: Proof of Concept Study in a Translational Monkey Bradykinin Challenge Model Apr 09, 2020 Poster 931.5 KB
